Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;13(1):e70131.
doi: 10.1002/iid3.70131.

Histogram of Apparent Diffusion Coefficient to Evaluate the Activity of Thyroid-Associated Ophthalmopathy

Affiliations

Histogram of Apparent Diffusion Coefficient to Evaluate the Activity of Thyroid-Associated Ophthalmopathy

Defu Li et al. Immun Inflamm Dis. 2025 Jan.

Abstract

Objective: This study aimed to evaluate the activity of extraocular muscles (EOMs) in patients with thyroid-associated ophthalmopathy (TAO) using turbo spin echo imaging. By analyzing tissue heterogeneity, apparent diffusion coefficient (ADC) histogram analysis offers enhanced insights into edema within the EOMs.

Methods: Eighty-eight patients with TAO were retrospectively evaluated and allocated into active (n = 24, clinical activity score [CAS] ≥ 3) and inactive (n = 64, CAS < 3) groups. The parameter values of the ADC histogram of EOMs were measured; the efficacy of ADC histograms in distinguishing between TAO activity and inactivity was assessed using receiver operating characteristic curves. Multifactorial logistic regression was used to determine active TAO predictors.

Results: The minimum, maximum, median, mean; and 1st, 5th, 10th, 25th, 75th, 90th, 95th, and 99th percentiles of the ADC histograms were higher in patients with active than that in participants with inactive TAO. The area under the curve (AUC) of the 10th percentile of the ADC histogram and the median distinguishing between active and inactive TAOs were both 0.791 (both p < 0.05), and the AUCs of the combined model of age, sex, smoking, and the 10th percentile in the ADC histogram were better than those of their individual models and the combined model of age, sex, and smoking (all p < 0.05). Smoking and male sex, along with the median > 1.26 μm2/s, entropy > 4.03, and standard deviation (SD) > 0.4 of the ADC histogram, were significant predictors of TAO activity, with odds ratios of 2.741 and 6.806, 5.070, 2.652, and 2.197, respectively (all p < 0.05).

Conclusion: ADC histograms provide a new method for distinguishing active from inactive TAO, and the 10th percentile enhances the clinical diagnosis of active TAO. In addition to male sex and smoking, an ADC histogram median > 1.26 μm²/s, entropy > 4.03, or SD > 0.4 may also predict active TAO.

Keywords: apparent diffusion coefficient; clinical activity score; extraocular muscle; intravoxel incoherent motion; thyroid‐associated ophthalmopathy; turbo spin echo.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Patient with active TAO (male, 46 years). A. DWI coronal image with b = 0, showing bilateral inflammatory edema of the medial and inferior rectus muscles and the right superior rectus muscle, with markedly increased signal. The blue‐yellow area of the right inferior rectus muscle is the area of interest at this level. (B) Histogram of the ADC of the right inferior rectus muscle, reflecting the distribution of each ADC value. ADC, apparent diffusion coefficient; DWI, diffusion‐weighted imaging; TAO, thyroid‐associated ophthalmopathy.
Figure 2
Figure 2
Comparison of area under the curves between models for differentiating between active and inactive thyroid‐related ophthalmopathy. 10th, 10th percentile of apparent diffusion coefficient histograms; p, p value.

References

    1. Taylor P. N., Zhang L., Lee R. W. J., et al., “New Insights Into the Pathogenesis and Nonsurgical Management of Graves Orbitopathy,” Nature Reviews Endocrinology 16 (2020): 104–116. - PubMed
    1. Douglas R. S., Kahaly G. J., Patel A., et al., “Teprotumumab for the Treatment of Active Thyroid Eye Disease,” New England Journal of Medicine 382 (2020): 341–352. - PubMed
    1. Park M., Kim J. Y., Kang J. M., et al., “PRL‐1 Overexpressed Placenta‐Derived Mesenchymal Stem Cells Suppress Adipogenesis in Graves' Ophthalmopathy Through SREBP2/HMGCR Pathway,” Stem Cell Research & Therapy 12 (2021): 304. - PMC - PubMed
    1. Siakallis L. C., Uddin J. M., and Miszkiel K. A., “Imaging Investigation of Thyroid Eye Disease,” Ophthalmic Plastic & Reconstructive Surgery 34 (2018): S41–S51. - PubMed
    1. Bartalena L., Baldeschi L., Boboridis K., et al., “The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy,” European Thyroid Journal 5 (2016): 9–26. - PMC - PubMed

Publication types

LinkOut - more resources